(4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

C30H31N5O7 — CID 137037777

IUPAC(4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
SMILESCN(C)c1cc(-c2nc3ccccc3[nH]2)c(O)c2c1C[C@H]1C[C@H]3C(N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C1C2=O
InChIInChI=1S/C30H31N5O7/c1-34(2)18-11-14(29-32-16-7-5-6-8-17(16)33-29)23(36)20-13(18)9-12-10-15-22(35(3)4)25(38)21(28(31)41)27(40)30(15,42)26(39)19(12)24(20)37/h5-8,11-12,15,19,21-22,36,42H,9-10H2,1-4H3,(H2,31,41)(H,32,33)/t12-,15-,19?,21?,22?,30-/m0/s1
InChIKeyMAXRYRKLOHTENT-YQNKTGMOSA-N
MW573.61 g/mol
LogP0.48
Rot. Bonds4

About (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

(4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide (PubChem CID 137037777) has the molecular formula C30H31N5O7 and a molecular weight of 573.61 g/mol. Its IUPAC name is (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide.

Molecular Properties

Compound Name(4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
PubChem CID137037777
Molecular FormulaC30H31N5O7
Molecular Weight573.61 g/mol
Exact Mass573.22
IUPAC Name(4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
SMILESCN(C)c1cc(-c2nc3ccccc3[nH]2)c(O)c2c1C[C@H]1C[C@H]3C(N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C1C2=O
InChIInChI=1S/C30H31N5O7/c1-34(2)18-11-14(29-32-16-7-5-6-8-17(16)33-29)23(36)20-13(18)9-12-10-15-22(35(3)4)25(38)21(28(31)41)27(40)30(15,42)26(39)19(12)24(20)37/h5-8,11-12,15,19,21-22,36,42H,9-10H2,1-4H3,(H2,31,41)(H,32,33)/t12-,15-,19?,21?,22?,30-/m0/s1
InChIKeyMAXRYRKLOHTENT-YQNKTGMOSA-N
XLogP0.48
TPSA186.99 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500573.61
LogP ≤ 50.48
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
The IUPAC name of (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide (CID 137037777) is (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide.
What is the SMILES notation for (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
The canonical SMILES for (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide is CN(C)c1cc(-c2nc3ccccc3[nH]2)c(O)c2c1C[C@H]1C[C@H]3C(N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C1C2=O.
What is the InChIKey of (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
The InChIKey is MAXRYRKLOHTENT-YQNKTGMOSA-N. The full InChI is InChI=1S/C30H31N5O7/c1-34(2)18-11-14(29-32-16-7-5-6-8-17(16)33-29)23(36)20-13(18)9-12-10-15-22(35(3)4)25(38)21(28(31)41)27(40)30(15,42)26(39)19(12)24(20)37/h5-8,11-12,15,19,21-22,36,42H,9-10H2,1-4H3,(H2,31,41)(H,32,33)/t12-,15-,19?,21?,22?,30-/m0/s1.
What are the key properties of (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
(4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide has a molecular weight of 573.61 g/mol, XLogP of 0.48, 4 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (4aS,5aR,12aS)-9-(1H-benzimidazol-2-yl)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide is sourced from PubChem (CID 137037777), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).